RenalGuard

develops Contrast-Induced Nephropathy for the cardiovascular treatment...
Read more
RenalGuard CEO: Jim Dillon

CEO

Jim Dillon

CEO Approval Rating

84/100

Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
25-100
Agree?
Funding
$21.5M

RenalGuard Competitors

1Skytron, LLC.
2Biotronik
3NAMSA
4Rhythm Xience
5OmniGuide
6STERIS
7Getinge
8DexCom
9Abbott
10PPD

Trending Companies